The Platelet Rich Plasma Market is witnessing robust growth as regenerative medicine and minimally invasive therapies gain widespread acceptance across healthcare systems. Platelet-rich plasma (PRP), derived from a patient’s own blood, is increasingly used to accelerate tissue repair, reduce inflammation, and enhance healing outcomes. Valued at USD 640.32 million in 2023, the market is...